During the past decade, Kenton Oncology, Incorporated conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kenton Oncology, Incorporated" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kenton Oncology, Incorporated" are "Breast Cancer" (6 trials), "Lung Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Anorexia" (1 trials) and "Cachexia" (1 trials). Many other conditions were trialed in "Kenton Oncology, Incorporated" in a lesser frequency.

Most popular intervention types in "Kenton Oncology, Incorporated" are "Drug" (14 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (4 trials), "docetaxel" (2 trials), "gefitinib" (2 trials), "gemcitabine hydrochloride" (2 trials) and "irinotecan hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kenton Oncology, Incorporated" are 9 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kenton Oncology, Incorporated". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Kenton Oncology, Incorporated, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kenton Oncology, Incorporated, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".